Effects of combined deferiprone and desferrioxamine iron chelating therapy in β-thalassemia major end-stage heart failure-Reference-Cited by-同舟云学术

Effects of combined deferiprone and desferrioxamine iron chelating therapy in β-thalassemia major end-stage heart failure

Author:

Porcu Maurizio¹,Landis Novella²,Salis Stefano¹,Corda Marco¹,Orrù Pierpaolo¹,Serra Emanuela¹,Usai Barbara¹,Matta Gildo³,Galanello Renzo⁴

Affiliation:

1. Division of Cardiology; Azienda Ospedaliera “G. Brotzu”, Via A. Ricchi 1 09134 Cagliari Italy

2. Division of Paediatrics; Ospedale “Crobu”, ASL 7 Carbonia Italy

3. Department of Imaging; Azienda Ospedaliera “G. Brotzu” Cagliari Italy

4. Department of Biomedical Science and Biotechnologies; Ospedale Regionale per le Microcitemie; ASL 8, Università degli Studi Cagliari Italy

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference18 articles.

3. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine;Borgna-Pignatti;Haematologica,2004

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献